The invention also relates to a composition comprising anantibody antagonist to c-Met and an aminoheteroaryl compound, particularlyas a medicament. The present invention also comprises a pharmaceuticalcomposition comprising said anti c-Met antibody and said amino-heteroarylcompound as combination products for simultaneous, separateor sequential use. The invention relates to the use of the composition ofthe invention for the treatment of cancer in a mammal.
